Acrux Ltd has released a press release.
Acrux CEO and Managing Director appointment
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Acrux
- Acrux receives $1.73m advance on FY25 R&D Tax Incentive
- Investor Presentation February 2025
- Appendix 4D and December 2024 Half Year Accounts
- Acrux CEO announces plan to retire
- Monthly Activities/Appendix 4C Cash Flow Report
Later from Acrux
- Dapsone 7.5%, Gel launched in the United States
- Receipt of second advance for FY25 R&D Tax Incentive
- Licensing partnership in Saudi Arabia for Dapsone 5%, Gel
- Appendix 4E and Full Year Statutory Accounts FY25
- Received $3.04m RDTI rebate for FY25
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux